Bessemer Group’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $1.5M | Buy |
|
|||||
|
2025
Q2 | $586K | Sell |
|
|||||
|
2025
Q1 | $772K | Sell |
|
|||||
|
2024
Q4 | $3.62M | Sell |
|
|||||
|
2024
Q3 | $5.52M | Buy |
|
|||||
|
2024
Q2 | $5.35M | Buy |
|
|||||
|
2024
Q1 | $4.89M | Buy |
|
|||||
|
2023
Q4 | $2.15M | Sell |
|
|||||
|
2023
Q3 | $2.28M | Sell |
|
|||||
|
2023
Q2 | $2.04M | Buy |
|
|||||
|
2023
Q1 | $2.09M | Sell |
|
|||||
|
2022
Q4 | $2.14M | Buy |
|
|||||
|
2022
Q3 | $2.02M | Buy |
|
|||||
|
2022
Q2 | $1.58M | Buy |
|
|||||
|
2022
Q1 | $1.84M | Buy |
|
|||||
|
2021
Q4 | $1.39M | Buy |
|
|||||
|
2021
Q3 | $905K | Buy |
|
|||||
|
2021
Q2 | $811K | Buy |
|
|||||
|
2021
Q1 | $662K | Buy |
|
|||||
|
2020
Q4 | $565K | Sell |
|
|||||
|
2020
Q3 | $60.4M | Buy |
|
|||||
|
2020
Q2 | $56.5M | Buy |
|
|||||
|
2020
Q1 | $43M | Buy |
|
|||||
|
2019
Q4 | $33M | Sell |
|
|||||
|
2019
Q3 | $31.9M | Sell |
|
|||||
|
2019
Q2 | $38.6M | Buy |
|
|||||
|
2019
Q1 | $255K | Buy |
|
|||||
|
2018
Q4 | $184K | Buy |
|
|||||
|
2018
Q3 | $163K | Sell |
|
|||||
|
2018
Q2 | $140K | Sell |
|
|||||
|
2018
Q1 | $304K | Buy |
|
|||||
|
2017
Q4 | $141K | Sell |
|
|||||
|
2017
Q3 | $297K | Buy |
|
|||||
|
2017
Q2 | $31K | Buy |
|
|||||
|
2017
Q1 | $10K | Sell |
|
|||||
|
2016
Q4 | $51K | Sell |
|
|||||
|
2016
Q3 | $63K | Sell |
|
|||||
|
2016
Q2 | $143K | Sell |
|
|||||
|
2016
Q1 | $198K | Buy |
|
|||||
|
2015
Q4 | $205K | Buy |
|
|||||
|
2015
Q3 | $116K | Buy |
|
|||||
|
2015
Q2 | $103K | Buy |
|
|||||
|
2015
Q1 | $13K | Buy |
|